Financials
| H1’25 Trading Update | Jul. 21, 2025 |
| Final Results | May. 19, 2025 |
| FY24 Trading Update | Feb. 17, 2025 |
| Half-year Report | Sep. 30, 2024 |
| Posting of Annual Report and Accounts & AGM notice | May. 31, 2024 |
| Final Results | May. 15, 2024 |
| Trading Update - Replacement | Feb. 07, 2024 |
Proxies
| Result of AGM | Jun. 26, 2025 |
| AGM Statement and Directorate Changes | Jun. 26, 2025 |
| Posting of AR&R and Notice of AGM | May. 30, 2025 |
| Result of AGM | Jun. 26, 2024 |
| AGM Statement and Directorate Succession Planning | Jun. 26, 2024 |
| Result of AGM | Jun. 27, 2023 |
| Posting of Annual Report and Notice of AGM | May. 26, 2023 |
Ownership Update
| Director/PDMR Share Dealing | Aug. 12, 2025 |
| Award of Shares under SIP and Director Dealings | Jul. 24, 2025 |
| PDMR Options Revision | Jul. 09, 2025 |
| Director/PDMR Shareholding | Jun. 02, 2025 |
| Holding(s) in Company | May. 27, 2025 |
| Holding(s) in Company | May. 23, 2025 |
| Holding(s) in Company | Apr. 01, 2025 |
Announcements
| Speedboat® patient testimonial | Aug. 04, 2025 |
| MicroBlate™ Flex begins lung tumour clinical study | Jul. 10, 2025 |
| Change of Nominated Adviser | Jun. 30, 2025 |
| U.S. FDA clearance for SpydrBlade™ Flex | Jun. 11, 2025 |
| US Reimbursement milestone for Speedboat procedure | May. 28, 2025 |
| Directorate changes | May. 22, 2025 |
| Notice of investor presentations | May. 06, 2025 |